CA Stock MarketDetailed Quotes
MYCO Mydecine Innovations Group Inc
- 0.010
- 0.0000.00%
15min DelayMarket Closed Dec 13 12:28 ET
617.55KMarket Cap-0.05P/E (TTM)
0.010High0.005Low505.80KVolume0.005Open0.010Pre Close5.04KTurnover0.11552wk High0.82%Turnover Ratio61.76MShares0.00552wk Low-0.2EPS TTM617.55KFloat Cap0.200Historical HighLossP/E (Static)61.76MShs Float0.005Historical Low-0.68EPS LYR50.00%Amplitude--Dividend TTM-0.04P/B1Lot Size--Div YieldTTM
Mydecine Innovations Group Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 305.54%49.57K | 98.81%-9.75K | 99.42%-17.3K | 47.25%-4.22M | 64.39%-372.69K | 98.10%-24.12K | 79.79%-819.54K | -85.05%-3M | 66.85%-7.99M | 83.44%-1.05M |
| Net income from continuing operations | -68.05%-1.99M | -6.10%-2.67M | 90.29%-1.02M | -33.04%-20.95M | -48.97%-6.78M | 59.78%-1.18M | 3.63%-2.52M | -85.59%-10.46M | 33.24%-15.75M | 60.33%-4.55M |
| Operating gains losses | -100.85%-466 | -304.71%-7.26K | 84.28%-8.36K | 1,016.94%8.83M | 813.66%8.83M | 356.91%54.92K | 100.56%3.55K | -105.95%-53.17K | -3,330.13%-963.52K | -308.52%-1.24M |
| Depreciation and amortization | --0 | --0 | --0 | -92.34%9.88K | -99.99%1 | -95.36%1.2K | -89.96%3.4K | -91.31%5.28K | -45.21%128.86K | -92.14%8.53K |
| Asset impairment expenditure | --0 | --0 | --0 | --1.29M | ---1 | --0 | --0 | --1.29M | --0 | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | --0 | --0 | ---5.14M | --0 | --0 | --5.14M | ---561.18K | ---- |
| Other non cashItems | 97.44%382.66K | 54.57%370.37K | 49.19%350.47K | 6.70%1.3M | 178.52%634.39K | -65.21%193.81K | 13.11%239.62K | 4.73%234.92K | 294.58%1.22M | 295.61%227.77K |
| Change In working capital | 81.80%1.65M | 58.53%2.3M | -22.88%656.28K | -33.16%5.3M | -58.86%2.09M | -15.39%908.91K | 237.65%1.45M | -70.01%851K | 272.54%7.93M | 455.65%5.07M |
| -Change in receivables | 25.46%26.78K | -87.51%28.86K | -303.45%-18.32K | 215.23%207.35K | 63.79%-54.16K | -3.21%21.35K | 699.06%231.15K | 111.07%9.01K | 5.88%-179.94K | -353.30%-149.57K |
| -Change in prepaid assets | --0 | -95.58%19.28K | --0 | -44.76%1.88M | -64.89%566.14K | -84.00%275.52K | 139.82%435.83K | -48.19%602.5K | 166.74%3.4M | 307.33%1.61M |
| -Change in payables and accrued expense | 165.60%1.63M | 187.07%2.25M | 181.67%674.6K | -31.74%3.21M | -56.37%1.57M | 191.35%612.05K | 7,328.91%785.16K | -86.36%239.5K | 574.89%4.7M | 556.42%3.61M |
| Cash from discontinued investing activities | 0 | -748.82%-433.36K | -112.92%-202.66K | |||||||
| Operating cash flow | 293.10%46.57K | 99.18%-6.75K | 99.42%-17.3K | 49.96%-4.22M | 70.17%-372.69K | 98.40%-24.12K | 79.79%-819.54K | -85.05%-3M | 64.96%-8.43M | 73.72%-1.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 1,498.97%525.2K | 100.00%1 | 0 | 25.2K | 500K | 92.07%-37.54K | 55.37%-37.54K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 91.23%-35.47K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2.08K | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | --525.2K | --1 | --0 | --25.2K | --500K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 1,498.97%525.2K | 100.00%1 | --0 | --25.2K | --500K | 92.07%-37.54K | 55.37%-37.54K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | -46.74%3.72M | -67.50%393K | -99.92%1K | -80.08%824.5K | 539.53%2.5M | -70.71%6.98M | -74.49%1.21M |
| Net issuance payments of debt | ---- | ---- | ---- | 50.39%110K | ---- | ---- | ---- | ---- | -98.67%73.14K | 100.36%35.65K |
| Net common stock issuance | --0 | --0 | --0 | -47.76%3.61M | -64.12%283K | -99.92%1K | -81.71%824.5K | 581.82%2.5M | -54.95%6.91M | --788.75K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | -46.74%3.72M | -66.51%393K | -99.92%1K | -80.08%824.5K | 539.53%2.5M | -70.71%6.98M | -75.24%1.17M |
| Net cash flow | ||||||||||
| Beginning cash position | -66.37%13.61K | 97.76%20.35K | 241.31%37.65K | -99.26%11.03K | -80.50%17.34K | -87.52%40.46K | -96.11%10.29K | -99.26%11.03K | -31.74%1.5M | -94.42%88.93K |
| Current changes in cash | 301.45%46.57K | -122.36%-6.75K | -2,240.32%-17.3K | 101.79%26.62K | 126.07%20.31K | 91.14%-23.12K | -64.61%30.16K | 99.94%-739 | -113.45%-1.48M | 20.29%-77.9K |
| End cash Position | 247.04%60.17K | -66.37%13.61K | 97.76%20.35K | 241.31%37.65K | 241.31%37.65K | -80.50%17.34K | -87.52%40.46K | -96.11%10.29K | -99.26%11.03K | -99.26%11.03K |
| Free cash from | 293.10%46.57K | 99.18%-6.75K | 99.42%-17.3K | 50.17%-4.22M | 70.99%-372.69K | 98.40%-24.12K | 79.79%-819.54K | -85.05%-3M | 65.39%-8.46M | 73.12%-1.28M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data